InfraScan, a Philadelphia medical device firm specializing in brain injury diagnostic products, said Wednesday it has enrolled 15 patients in a clinical trial testing an experimental device designed to detect bleeding in the brain. The study is taking place at the Hospital of the University of Pennsylvania in Philadelphia and Baylor College of Medicine in Houston.
